microdosing glp-1 for menopause GLP‑1 in & Perimenopause Menopause Weight Challenges: GLP-1 ID
Description
Shapsis will determine the right medication and dosage based on your medical profile
The one that fits YOUR health goals
Semaglutide has transformed weight loss treatment for millions of patients, but emerging anecdotal reports suggest a potential link between GLP-1 receptor agonists and obsessive-compulsive symptoms in some individuals
Why This Program Is Different Than Other Weight Loss Programs
Our doctors help with long-term weight management plans to support your continuing health journey
The dose escalation phase usually lasts 812 weeks before reaching a maintenance dose where weight loss becomes consistent and predictable
